Tarsus Pharmaceuticals, Inc. - Common Stock (TARS)
CUSIP: 87650L103
Q3 2021 13F Holders as of 30 Sep 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,450,857
- Total 13F shares
- 12,869,541
- Share change
- -452,111
- Total reported value
- $277,366,339
- Price per share
- $21.55
- Number of holders
- 43
- Value change
- -$12,449,066
- Number of buys
- 15
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 87650L103?
CUSIP 87650L103 identifies TARS - Tarsus Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 87650L103:
Top shareholders of TARS - Tarsus Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Vivo Capital, LLC |
13F
|
Company |
7%
|
2,987,331
|
$86,573,000 | — | 30 Jun 2021 | |
| RTW INVESTMENTS, LP |
13F
3/4/5
|
Company · 10%+ Owner |
4.7%
|
2,013,601
|
$58,354,000 | — | 30 Jun 2021 | |
| Cormorant Asset Management, LP |
13F
|
Company |
3.6%
|
1,514,269
|
$43,884,000 | — | 30 Jun 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
3.3%
|
1,417,157
|
$41,069,000 | — | 30 Jun 2021 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.1%
|
1,296,416
|
$37,570,000 | — | 30 Jun 2021 | |
| TimesSquare Capital Management, LLC |
13F
|
Company |
1.6%
|
686,705
|
$19,901,000 | — | 30 Jun 2021 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
1.2%
|
514,289
|
$14,904,000 | — | 30 Jun 2021 | |
| Jefferies Group LLC |
13F
|
Company |
1%
|
442,993
|
$12,837,937 | — | 30 Jun 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1%
|
438,356
|
$12,703,000 | — | 30 Jun 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
1%
|
426,045
|
$12,347,000 | — | 30 Jun 2021 | |
| SANDS CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
260,000
|
$7,535,000 | — | 30 Jun 2021 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.47%
|
200,000
|
$5,797,000 | — | 30 Jun 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.4%
|
170,000
|
$4,927,000 | — | 30 Jun 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
125,521
|
$3,637,000 | — | 30 Jun 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.28%
|
119,141
|
$3,453,000 | — | 30 Jun 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.19%
|
79,635
|
$2,308,000 | — | 30 Jun 2021 | |
| Altium Capital Management LLC |
13F
|
Company |
0.17%
|
70,573
|
$2,045,000 | — | 30 Jun 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.11%
|
46,573
|
$1,350,000 | — | 30 Jun 2021 | |
| J. Goldman & Co LP |
13F
|
Company |
0.08%
|
33,751
|
$978,000 | — | 30 Jun 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.07%
|
30,428
|
$882,000 | — | 30 Jun 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.06%
|
26,880
|
$779,000 | — | 30 Jun 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
25,723
|
$745,000 | — | 30 Jun 2021 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.05%
|
22,977
|
$666,000 | — | 30 Jun 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
21,573
|
$625,000 | — | 30 Jun 2021 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.04%
|
16,686
|
$484,000 | — | 30 Jun 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
11,644
|
$337,000 | — | 30 Jun 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
9,353
|
$271,000 | — | 30 Jun 2021 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
8,600
|
$249,000 | — | 30 Jun 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
8,282
|
$241,000 | — | 30 Jun 2021 | |
| Hunter Perkins Capital Management, LLC |
13F
|
Company |
0.02%
|
7,780
|
$225,000 | — | 30 Jun 2021 | |
| VIRTUS ADVISERS, LLC |
13F
|
Company |
0.01%
|
6,319
|
$183,000 | — | 30 Jun 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
5,574
|
$161,000 | — | 30 Jun 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
5,162
|
$150,000 | — | 30 Jun 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
4,724
|
$137,000 | — | 30 Jun 2021 | |
| Jason E. Tester |
3/4/5
|
Director, 10%+ Owner |
—
class O/S missing
|
10,000
|
$109,900 | — | 15 Jun 2021 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,100
|
$60,000 | — | 30 Jun 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,960
|
$57,000 | — | 30 Jun 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,173
|
$34,000 | — | 30 Jun 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
818
|
$24,000 | — | 30 Jun 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
577
|
$17,000 | — | 30 Jun 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
515
|
$15,000 | — | 30 Jun 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
401
|
$12,000 | — | 30 Jun 2021 | |
| Spire Wealth Management |
13F
|
Company |
0%
|
100
|
$3,000 | — | 30 Jun 2021 | |
| SIGNATUREFD, LLC |
13F
|
Company |
0%
|
27
|
$1,000 | — | 30 Jun 2021 | |
| TUCKER ASSET MANAGEMENT LLC |
13F
|
Company |
0%
|
4
|
$116 | — | 30 Jun 2021 |
Institutional Holders of Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) as of Q3 2021
As of 30 Sep 2021,
Tarsus Pharmaceuticals, Inc. - Common Stock (TARS) was held by
43 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,869,541 shares.
The largest 10 holders included
Vivo Capital, LLC, RTW INVESTMENTS, LP, Cormorant Asset Management, LP, FRAZIER MANAGEMENT LLC, PERCEPTIVE ADVISORS LLC, TimesSquare Capital Management, LLC, COWEN AND COMPANY, LLC, BlackRock Inc., VANGUARD GROUP INC, and Jefferies Group LLC.
This page lists
43
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
44
Q3 2021 holders
43
Holder diff
-1
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 Value $ | Q3 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.